BIOMAT Database Logo BIOMAT Database Logo

[Letter: Narcolepsy. Suppression of paradoxical sleep by L-dopa]. 1976

J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009290 Narcolepsy A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7) Gelineau Syndrome,Narcolepsy-Cataplexy Syndrome,Paroxysmal Sleep,Gelineau's Syndrome,Narcoleptic Syndrome,Gelineau's Syndromes,Gelineaus Syndrome,Narcolepsy Cataplexy Syndrome,Narcolepsy-Cataplexy Syndromes,Narcoleptic Syndromes,Sleep, Paroxysmal,Syndrome, Gelineau,Syndrome, Gelineau's,Syndrome, Narcolepsy-Cataplexy,Syndrome, Narcoleptic,Syndromes, Gelineau's,Syndromes, Narcolepsy-Cataplexy,Syndromes, Narcoleptic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006719 Homovanillic Acid A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid. 3-Methoxy-4-Hydroxyphenylacetic Acid,4-Hydroxy-3-Methoxyphenylacetic Acid,3 Methoxy 4 Hydroxyphenylacetic Acid,4 Hydroxy 3 Methoxyphenylacetic Acid,Acid, 3-Methoxy-4-Hydroxyphenylacetic,Acid, 4-Hydroxy-3-Methoxyphenylacetic,Acid, Homovanillic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006897 Hydroxyindoleacetic Acid 5-HIAA,5-Hydroxy-3-Indoleacetic Acid,5-Hydroxyindolamine Acetic Acid,5 Hydroxy 3 Indoleacetic Acid,5 Hydroxyindolamine Acetic Acid,Acetic Acid, 5-Hydroxyindolamine,Acid, 5-Hydroxy-3-Indoleacetic,Acid, 5-Hydroxyindolamine Acetic,Acid, Hydroxyindoleacetic

Related Publications

J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
[Narcolepsy and paradoxical sleep].
January 1971, Saishin igaku. Modern medicine,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
L-dopa and narcolepsy.
August 1992, Neurology,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
Effect of L-dopa on periodic movements in sleep in narcolepsy.
January 1987, European neurology,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
Reduction in paradoxical sleep after L-dopa administration in rats.
November 1986, Behavioral and neural biology,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
Letter: Paradoxical suppression of chorea by apomorphine.
September 1974, JAMA,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
[Letter: A severe case of postural hypotension. Paradoxical treatment by L-dopa combined with an inhibitor of extracerebral dopa-decarboxylase].
February 1975, La Nouvelle presse medicale,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
Paradoxical sleep in psychiatric disorders and narcolepsy.
January 1981, International journal of neurology,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
[Letter: Treatment of vitiligo by L Dopa].
January 1974, La Nouvelle presse medicale,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy.
August 1989, Clinical neuropharmacology,
J C Gilbert, and J C Willer, and C Bernheim-Chatelain, and M Ecoffet, and P Jaillon
Preliminary clinical trial with L-DOPA in Narcolepsy.
January 1971, Psychopharmacologia,
Copied contents to your clipboard!